91探花

Authored by Les-leigh A

Let鈥檚 be honest 鈥� nobody saw quite how fast this would move.

In just a few months, Microsoft, Amazon and OpenAI have all planted flags in consumer health AI. Microsoft鈥檚 Copilot Health went live this month, built as a secure, standalone space inside Copilot where your wearables, lab results and medical records actually start talking to each other. Amazon wasn鈥檛 far behind, launching its Health AI assistant with a focus on the practical stuff: booking appointments, making sense of prescriptions, explaining what your records actually mean. Furthermore, OpenAI鈥檚 ChatGPT Health and Anthropic鈥檚 Claude for Healthcare made their debut in January.

Four of the biggest names in tech. One sector. A matter of months. For the HealthTech startups who鈥檝e been quietly building in this space for years, it鈥檚 a lot to absorb.

Why Big Tech Wants Your Health Data

Here鈥檚 the thing about health data: there鈥檚 an enormous amount of it, and almost none of it is being used well. Your GP has one set of records. Your hospital has another. Your Garmin or Apple Watch is collecting data that never makes it anywhere meaningful. It鈥檚 fragmented, siloed and mostly useless in its current state.

That鈥檚 the gap these platforms are going after. The pitch isn鈥檛 complicated: let us bring it all together and we鈥檒l show you something useful. Microsoft is emphasising the trust angle with Copilot Health, which makes sense given how sensitive this data is. Amazon is going more practical 鈥� less 鈥渋nsight鈥�, more 鈥渉ere鈥檚 what your prescription actually means and here鈥檚 where to get it filled.鈥� OpenAI is targeting medical record integration.聽

Different entry points, same destination.

Whoever gains the trust of consumers and healthcare providers in this space will possess one of the most valuable data assets imaginable. That鈥檚 why the debate around data ownership and AI is only getting louder. And the health sector just turned the volume up significantly.
 

What Happens To The Startups Already In This Space?

This is the question worth contemplating. The arrival of Big Tech in a market does two things simultaneously: it validates everything the early builders were doing, while also making their lives considerably harder.

The data problem is the most critical part of this. Microsoft and Amazon enter the space with existing relationships across hospitals, insurers and enterprise health systems. They don鈥檛 need to build trust from scratch in the way a Series A startup has to. They already have distribution and data – these are the chief advantages.

But healthcare isn鈥檛 like other markets. Clinical accuracy matters in a way it simply doesn鈥檛 in, say, productivity software – getting it wrong has real consequences. And that means regulatory compliance, rigorous testing and genuine clinical credibility aren鈥檛 optional extras 鈥� they鈥檙e everything. UK and European startups, working within GDPR and the EU AI Act, are actually positioned well here. The constraints that feel like friction are also what builds credibility. Startups like Matresa, tackling maternal health in the UK with a clinically grounded approach, are a good example of what that looks like in practice.

It鈥檚 worth noting that we鈥檝e seen these dynamics before, just in a different corner of tech. The fitness and wearables data space has spent years working through exactly these questions about who owns user data, who controls it and what happens when big platforms decide they want a piece of it. Health AI is heading down the same road, just with higher stakes.

The Opportunity Hidden In The Noise

So is this purely bad news for HealthTech startups? Not really, no.

When a market gets this kind of attention from players with Microsoft and Amazon鈥檚 marketing budgets, the entire category inevitably grows. Consumer awareness of health AI is about to jump in a way that no startup could have driven on its own. More people engaging with digital health tools means a bigger overall market, and that includes the more specialised players building for specific conditions, communities or care pathways.

The startups with the strongest position going forward are the ones doing things the general-purpose platforms genuinely can鈥檛. Women鈥檚 health. Rare diseases. Mental health. Post-operative care. Chronic condition management. These aren鈥檛 areas where scale alone wins. They鈥檙e areas where clinical depth, community trust and real specialist knowledge are the differentiators. These things don鈥檛 come from a platform launch, however well-funded.

Big Tech is coming for health data. That much is clear. But the companies building something specific, human and genuinely trusted? There鈥檚 still a lot of room for them.